Primary aldosteronism
Conditions
Interventions
the spironolactone treatment group:NA
the surgical treatment group:NA
Sponsors
Department of Endocrinology, the First Affiliated Hospital of China Medical University
Eligibility
Sex/Gender
All
Age
33 Years to 83 Years
Inclusion criteria
Inclusion criteria: ? The CT diagnosis was adrenal tumor. ? In the First Affiliated Hospital of China Medical University, spironolactone was used for treatment or adrenal tumor resection
Exclusion criteria
Exclusion criteria: (1) excessive alcohol consumption (more than 140 grams per week for males and 70 grams per week for females); (2) history of viral hepatitis, autoimmune hepatitis, or other chronic liver diseases; (3) self-reported acute infection within the past 2 weeks; (4) body mass index (BMI) less than 18.0 kilograms per square meter.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiovascular disease;non-alcoholic fatty liver disease; | — |
Secondary
| Measure | Time frame |
|---|---|
| BMI;blood pressure;WBC;glu;Hb1Ac;AST;ALT;ALP;GGT;TBIL;TG;TC;HDL;LDL;CRP;IRI; | — |
Countries
China
Contacts
Public ContactYanli Cao
The First Affiliated Hospital of China Medical University
Outcome results
None listed